Complete your 2017 Europe Annual Conference experience by adding on a plant tour. Options in the Barcelona area include:
Additional details for each tour are listed below. Secure your spot now – spaces are limited!
Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. We accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care. We have three primary divisions – Bioscience, Diagnostic and Hospital – which develop, produce and market our innovative products and services to medical professionals in more than 90 countries around the world. The Grifols fractionation plant is a design of Grifols Engineering and was opened in 2014. The plant is liscensed by the FDA and European healthcare authorities and uses state-of-the-art technology for plasma fractionation.
Almirall is a global company based in Barcelona dedicated to providing valuable medicines and medical devices through its R&D, agreements, and alliances. Our work covers the whole of the drug value chain. A consolidated growth allows us to devote our talent and efforts towards speciality areas and particularly to further grow as a leading dermatology player. We are a specialist company, enabling us to accomplish the purpose of taking our innovative products wherever they are needed. Founded in 1943, Almirall is listed on the Spanish Stock Exchange (ticker: ALM) and it has become a source of value creation for society due to its vision and the commitment of its long-standing major shareholders. With 1.800 employees, it has gradually built up a trusted presence across Europe, as well as in the USA.
Barcelona Biomedical Research Park (PRBB)
The PRBB is one of the largest biomedical research hubs in Southern Europe with a critical mass of 1.500 people in 6 independent research centres sharing a cutting-edge scientific infrastructure in a singular building at the beach of Barcelona, next to the Hospital del Mar. The focus of research is translational, combining the molecular, clinical, and populational perspective. The scientific activity is characterized by a yearly output of 1.200 scientific publications, 20 of them in Nature or Science, 300 scientific conferences, an accumulated R&D budget of approximately 90 M€, and more than 20 researchers holding a prestigious grant from the European Research Council (ERC).